Opposing function of MYBBP1A in proliferation and migration of head and neck squamous cell carcinoma cells

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Acuña Sanhueza, Gustavo A ^a,b   Faller, Leonie ^a   George, Babitha ^a   Koffler, Jennifer ^a   Misetic, Vinko ^a   Flechtenmacher, Christa ^a   Dyckhoff, Gerhard ^a   Plinkert, Peter P ^a   Angel, Peter ^b   Simon, Christian ^a   Hess, Jochen ^a,b  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYB BINDING PROTEIN 1A; PROTEIN P53; REGULATOR PROTEIN; TUMOR PROTEIN; UNCLASSIFIED DRUG; MYBBP1A PROTEIN, HUMAN; NUCLEAR PROTEIN; NUCLEOCYTOPLASMIC TRANSPORT PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CARCINOMA CELL; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE INTERACTION; GENE SILENCING; GENE SWITCHING; GENETIC CODE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOLECULAR PATHOLOGY; MOUSE; MOUTH CANCER; MYB BINDING PROTEIN 1A GENE; NONHUMAN; PRIMARY TUMOR; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECURRENT CANCER; REGULATOR GENE; TRANSCRIPTION REGULATION; ANIMAL; CELL MOTION; DISEASE MODEL; GENETICS; METABOLISM; MOUTH TUMOR; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; TUMOR RECURRENCE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MOUTH NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NUCLEAR PROTEINS; NUCLEOCYTOPLASMIC TRANSPORT PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84857011111     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-72     Document Type: Article

References (26)

1. Argiris A, Karamouzis MV, Raben D, Ferris RL. Head and neck cancer. Lancet 2008, 371:1695-1709. 10.1016/S0140-6736(08)60728-X, 18486742.
2. Leemans C, Braakhuis B, Brakenhoff R. The molecular biology of head and neck cancer. Nat Rev Cancer 2011, 11:9-22. 10.1038/nrc2982, 21160525.
3. Forastiere A, Koch W, Trotti A, Sidransky D. Head and neck cancer. N Engl J Med 2001, 345:1890-1900. 10.1056/NEJMra001375, 11756581.
4. Hunter KD, Parkinson EK, Harrison PR. Profiling early head and neck cancer. Nat Rev Cancer 2005, 5:127-135. 10.1038/nrc1549, 15685196.
5. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T. Cancer statistics. CA Cancer J Clin 2008, 58:71-96. 10.3322/CA.2007.0010, 18287387.
6. Thomas GR, Nadiminti H, Regalado J. Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma. Int J Exp Pathol 2005, 86:347-363. 10.1111/j.0959-9673.2005.00447.x, 2517451, 16309541.
7. Smith LP, Thomas GR. Animal models for the study of squamous cell carcinoma of the upper aerodigestive tract: a historical perspective with review of their utility and limitations. Part A. Chemically-induced de novo cancer, syngeneic animal models of HNSCC, animal models of transplanted xenogeneic human tumors. Int J Cancer 2006, 118:2111-2122. 10.1002/ijc.21694, 16380986.
8. Behren A, Kamenisch Y, Muehlen S, Flechtenmacher C, Haberkorn U, Hilber H. Development of an oral cancer recurrence mouse model after surgical resection. Int J Oncol 2010, 36:849-855.
9. Favier D, Gonda TJ. Detection of proteins that bind to the leucine zipper motif of c-Myb. Oncogene 1994, 9:305-311.
10. Tavner FJ, Simpson R, Tashiro S, Favier D, Jenkins NA, Gilbert DJ. Molecular cloning reveals that the p160 Myb-binding protein is a novel, predominantly nucleolar protein which may play a role in transactivation by Myb. Mol Cell Biol 1998, 18:989-1002. 108811, 9447996.
11. Owen HR, Elser M, Cheung E, Gersbach M, Kraus WL, Hottiger MO. MYBBP1a is a novel repressor of NF-kappaB. J Mol Biol 2007, 366:725-736. 10.1016/j.jmb.2006.11.099, 17196614.
12. Roesch Ely M, Nees M, Karsai S, Magele I, Bogumil R, Vorderwulbecke S. Transcript and proteome analysis reveals reduced expression of calgranulins in head and neck squamous cell carcinoma. Eur J Cell Biol 2005, 84:431-444. 10.1016/j.ejcb.2005.01.003, 15819419.
13. Gebhardt C, Riehl A, Durchdewald M, Nemeth J, Furstenberger G, Muller-Decker K. RAGE signaling sustains inflammation and promotes tumor development. J Exp Med 2008, 205:275-285. 10.1084/jem.20070679, 2271015, 18208974.
14. Hess J, Porte D, Munz C, Angel P. AP-1 and Cbfa/runt physically interact and regulate parathyroid hormone-dependent MMP13 expression in osteoblasts through a new osteoblast-specific element 2/AP-1 composite element. J Biol Chem 2001, 2001(276):20029-20038.
15. Pettus JR, Johnson JJ, Shi Z, Davis JW, Koblinski J, Ghosh S. Multiple kallikrein (KLK 5, 7, 8, and 10) expression in squamous cell carcinoma of the oral cavity. Histol Histopathol 2009, 24:197-207. 2835693, 19085836.
16. Borgono CA, Diamandis EP. The emerging roles of human tissue kallikreins in cancer. Nat Rev Cancer 2004, 4:876-890. 10.1038/nrc1474, 15516960.
17. Sharma B, Sriram G, Saraswathi TR, Sivapathasundharam B. Immunohistochemical evaluation of mast cells and angiogenesis in oral squamous cell carcinoma. Indian J Dent Res 2010, 21:260-265. 10.4103/0970-9290.66655, 20657098.
18. Cheung ST, Leung KL, Ip YC, Chen X, Fong DY, Ng IO. Claudin-10 expression level is associated with recurrence of primary hepatocellular carcinoma. Clin Cancer Res 2005, 11:551-556.
19. Wolf JS, Li G, Varadhachary A, Petrak K, Schneyer M, Li D. Oral lactoferrin results in T cell-dependent tumor inhibition of head and neck squamous cell carcinoma in vivo. Clin Cancer Res 2007, 13:1601-1610. 10.1158/1078-0432.CCR-06-2008, 1810394, 17332307.
20. Varadhachary A, Wolf JS, Petrak K, O'Malley BW, Spadaro M, Curcio C. Oral lactoferrin inhibits growth of established tumors and potentiates conventional chemotherapy. Int J Cancer 2004, 111:398-403. 10.1002/ijc.20271, 15221967.
21. Yamauchi T, Keough RA, Gonda TJ, Ishii S. Ribosomal stress induces processing of Mybbp1a and its translocation from the nucleolus to the nucleoplasm. Genes Cells 2008, 13:27-39.
22. Perrera C, Colombo R, Valsasina B, Carpinelli P, Troiani S, Modugno M. Identification of Myb-binding protein 1A (MYBBP1A) as a novel substrate for aurora B kinase. J Biol Chem 2010, 285:11775-11785. 10.1074/jbc.M109.068312, 2852913, 20177074.
23. Tsuchiya M, Katagiri N, Kuroda T, Kishimoto H. Critical role of the nucleolus in activation of the p53-dependent postmitotic checkpoint. Biochem Biophys Res Commun 2011, 407:378-382. 10.1016/j.bbrc.2011.03.029, 21396915.
24. Kuroda T, Murayama A, Katagiri N, Ohta Y, Fujita E, Masumoto H, Ema M, Takahashi S, Kimura K, Yanagisawa J. RNA content in the nucleolus alters p53 acetylation via MYBBP1A. EMBO J 2011, 30:1054-1066. 10.1038/emboj.2011.23, 3061030, 21297583.
25. Molinolo A, Amornphimoltham P, Squarize CH, Castilho RM, Patel V, Gutkind JS. Dysregulated molecular networks in head and neck carcinogenesis. Oral Oncol 2009, 45:324-334. 10.1016/j.oraloncology.2008.07.011, 2743485, 18805044.
26. Kuwabara T, Hiyama T, Tanaka S, Yoshihara M, Arihiro K, Chayama K. Genetic pathways of multiple esophageal squamous cell carcinomas. Onco Rep 2011, 25:453-459.